Article

GLP in Type 2 Diabetes: Part 2

Part 2 of this program delves deeper into glucagon-like peptide-1, or GLP-1, and its therapeutic potential in type 2 diabetes. Click here to learn more.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image Credit: shidlovski | stock.adobe.com
Related Content
Some ampoules with covid-19 vaccine and syringe injection. Pandemic time. | Image Credit: Daniel Jędzura | stock.adobe.com
September 17th 2025

West Coast Health Alliance Sets Clinical Priorities Amid Vaccine Guidance Shifts

Danielle Valletti, Assistant Editor
Pharmacy Focus Oncology Edition Podcast
September 17th 2025

Protecting Community Oncology Practices in the Wake of the IRA

Alexandra Gerlach, Associate Editor
Food insecurity inscription displayed on plate against blue backdrop
September 17th 2025

Food Insecurity Associated With Increased Risk of Post-COVID-19 Condition

Luke Halpern, Assistant Editor
From Guidelines to Action: Pharmacy’s Role in Hypertension Management
September 17th 2025

From Guidelines to Action: Pharmacy’s Role in Hypertension Management

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Miniature traveler looking for vaccine | Image Credit: © Yuan - stock.adobe.com
September 17th 2025

Rising Infectious Disease Threats Highlight Importance of Travel Vaccines

Alexandra Gerlach, Associate Editor
Vintage 1951 Vial of PENICILLIN G Produced by CSC Pharmaceuticals division of Commercial Solvents Corporation, New York, USA | Image Credit: Walter Cichetti | stock.adobe.com
September 17th 2025

Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation

Caitlyn Jerkins, PharmD Tracey Bastian, PharmD Rebecca Stern, MD Tyler Baumeister, PharmD, BCIDP
© 2025 MJH Life Sciences

All rights reserved.